Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
BACKGROUND: Multiple sclerosis results from T-cell-dependent inflammatory demyelination of the central nervous system. Our objective was long-term suppression of inflammation with short-term monoclonal antibody treatment. METHODS: We depleted 95% of circulating lymphocytes in 27 patients with multi...
المؤلفون الرئيسيون: | Coles, A, Wing, M, Smith, S, Coraddu, F, Greer, S, Taylor, C, Weetman, A, Hale, G, Chatterjee, V, Waldmann, H, Compston, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
1999
|
مواد مشابهة
-
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
حسب: Coles, A, وآخرون
منشور في: (1999) -
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
حسب: Coles, A, وآخرون
منشور في: (2006) -
Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.
حسب: Waldmann, H, وآخرون
منشور في: (1992) -
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
حسب: Lim, S, وآخرون
منشور في: (1993) -
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
حسب: Moreau, T, وآخرون
منشور في: (1996)